David Bridge
About David Bridge
David Bridge is a seasoned quality assurance executive with over 30 years of experience, currently serving as the VP of Quality Assurance and Process Development.
VP of Quality Assurance and Process Development
David Bridge currently holds the title of Vice President of Quality Assurance and Process Development. His role involves overseeing and improving the quality assurance processes within the organization. With a focus on maintaining high standards, he ensures that products and procedures meet regulatory requirements and industry standards.
David Bridge's 30 Years of Quality Assurance Experience
David Bridge has amassed over 30 years of experience in the field of quality assurance. Throughout his extensive career, he has held various positions that have honed his expertise in quality management, regulatory compliance, and process development. His decade-spanning career reflects a deep commitment to advancing quality standards within the industries he has served.
Director of Quality Assurance at Duke University Clinical Research Institute
David Bridge previously served as the Director of Quality Assurance at the Duke University Clinical Research Institute. In this role, he was responsible for ensuring that clinical research programs complied with regulatory standards and achieved high levels of quality. His leadership contributed to the integrity and reliability of clinical research conducted at the institute.
Senior Director of Quality Assurance for Chimerix
David Bridge worked as the Senior Director of Quality Assurance for Chimerix, a biopharmaceutical company known for developing antiviral therapies. His responsibilities included managing the quality assurance strategies to support the development of innovative treatments. His contributions helped ensure that the company's products adhered to rigorous quality and regulatory standards.
Clinical Quality Assurance Leader at EMD Pharmaceuticals
Earlier in his career, David Bridge was a Clinical Quality Assurance Leader at EMD Pharmaceuticals, the U.S. affiliate for Merck KGaA. In this capacity, he oversaw the quality assurance processes for clinical trials, ensuring that they met both internal and external regulatory requirements. His work helped maintain the integrity and quality of clinical research efforts.